Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.28 USD | +1.75% | +5.33% | +42.77% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.77% | 589M | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-10.51% | 33.72B | |
+59.25% | 26.11B | |
-20.09% | 14.63B | |
-8.92% | 12.84B | |
-11.46% | 11.66B | |
-43.05% | 11.52B | |
+4.34% | 8.92B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating